Skip to main content
DNA Labs India

Immunohistochemistry Serum Associated Amyloid (SAA) Test

DNA Labs India | ISO 9001:2015 Certified

Immunohistochemistry Serum Associated Amyloid (SAA) Test

Short Name: IHC SAA Test

Also known as: IHC Amyloid A Test, SAA Immunohistochemistry, Amyloid A Tissue Staining Test, IHC for AA Amyloidosis, Serum Amyloid A Tissue Test

Immunohistochemistry Serum Associated Amyloid (SAA) Test test available at DNA Labs India for ₹3,500. Uses Immunohistochemistry (IHC), Peroxidase-antiperoxidase staining, Avidin-biotin complex method on Tissue samples. Results in Sample received daily by 6 PM. Report turnaround: Block samples 5 days, Tissue biopsy 5 days, Large complex tissue 7 business days.. Free home collection in 300+ cities across India.

ImmunohistochemistryAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the Immunohistochemistry Serum Associated Amyloid (SAA) Test is to detect, identify, and classify amyloid A (AA) protein deposits in tissue specimens using immunohistochemical staining. This test helps clinicians confirm a diagnosis of AA amyloidosis, distinguish it from other amyloid subtypes (such as AL amyloidosis and transthyretin amyloidosis), determine the extent and distribution of amyloid deposition within affected tissues, guide appropriate treatment strategies targeting the underlying inflammatory condition, and monitor disease progression or treatment response in patients with known chronic inflammatory disorders.

Test Code
1038
CPT Code
88342
ICD Code
E85.9
Price
₹3,500
Sample Type
Tissue
Result Time
Sample received daily by 6 PM. Report turnaround: Block samples 5 days, Tissue biopsy 5 days, Large complex tissue 7 business days.
Fasting Required
No
Method
Immunohistochemistry (IHC), Peroxidase-antiperoxidase staining, Avidin-biotin complex method
Step 1

Sample Collection

A tissue biopsy must be performed by a qualified physician or surgeon. Ensure the biopsy is representative of the affected area. Provide a copy of the histopathology report, biopsy site, and relevant clinical history. No patient-specific preparation is required for the IHC test itself.

Method: Tissue biopsy - surgical or core needle biopsy

Step 2

Laboratory Analysis

The tissue sample should be immediately placed in 10% formal-saline or processed as a formalin-fixed paraffin-embedded (FFPE) block. Adequate tissue size is required for proper embedding and sectioning. Label the container with patient details and biopsy site.

Step 3

Report Delivery

Ship the sample at room temperature. Include a completed test requisition form with the histopathology report, biopsy site, and clinical history. The laboratory will perform immunohistochemical staining and pathologist interpretation.

Timeline: Sample received daily by 6 PM. Report turnaround: Block samples 5 days, Tissue biopsy 5 days, Large complex tissue 7 business days.

Patient Instructions

1
Before the Test:No specific patient preparation is required for the IHC SAA test itself. The tissue biopsy must be collected by a physician and properly fixed. A copy of the histopathology report, biopsy site, and clinical history must be submitted with the sample.
2
During the Test:In the laboratory, thin sections are cut from the FFPE tissue block, placed on glass slides, and subjected to immunohistochemical staining using anti-SAA primary antibodies. Staining is performed using standard IHC protocols with appropriate antigen retrieval, and slides are examined by a pathologist.
3
After the Test:After pathologist interpretation, a detailed report is generated indicating the presence or absence of SAA amyloid deposits, staining pattern, and clinical correlation. The report is delivered through the patient portal, email, or WhatsApp as selected.

About This Test

Who Should Get This Test

The purpose of the Immunohistochemistry Serum Associated Amyloid (SAA) Test is to detect, identify, and classify amyloid A (AA) protein deposits in tissue specimens using immunohistochemical staining. This test helps clinicians confirm a diagnosis of AA amyloidosis, distinguish it from other amyloid subtypes (such as AL amyloidosis and transthyretin amyloidosis), determine the extent and distribution of amyloid deposition within affected tissues, guide appropriate treatment strategies targeting the underlying inflammatory condition, and monitor disease progression or treatment response in patients with known chronic inflammatory disorders.

How to Prepare

  • Submit tumor tissue in 10% formal-saline or as a formalin-fixed paraffin-embedded (FFPE) block
  • Ship the sample at room temperature
  • Provide a copy of the histopathology report along with the sample
  • Mention the exact site of biopsy on the requisition form
  • Include relevant clinical history including chronic inflammatory conditions and prior test results

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"AA amyloidosis is a serious complication of chronic inflammatory diseases such as rheumatoid arthritis, tuberculosis, and inflammatory bowel disease. Immunohistochemistry for SAA is the gold-standard tissue-based method for confirming AA amyloid deposits and distinguishing them from other amyloid types (AL, ATTR, etc.). Early detection through IHC enables timely intervention, including treatment of the underlying inflammatory condition, which can halt or even reverse amyloid deposition. If a patient with a known chronic inflammatory disease develops unexplained renal, hepatic, or cardiac dysfunction, tissue biopsy with SAA immunohistochemistry should be strongly considered."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeTissue
Sample VolumeAs received
Container10% Formal-saline container OR Formalin Fixed Paraffin Embedded (FFPE) block
Collection MethodTissue biopsy - surgical or core needle biopsy

Sample Stability

Room Temperature (FFPE block)
Formalin-fixed tissue
Sample Rejection Criteria:
  • Tissue sample received without formalin fixation or FFPE processing
  • Sample received without histopathology report or clinical history
  • Completely necrotic or autolyzed tissue with no viable diagnostic material
  • Sample container leaking or unlabeled
  • Bone tissue samples with evidence of excessive decalcification damage

Understanding Your Results

Results of the Immunohistochemistry SAA Test are interpreted by a qualified pathologist in conjunction with clinical findings, Congo Red staining results, and other ancillary investigations. The result is reported as either positive or negative for SAA amyloid deposition.
📊

Negative for SAA Amyloid

No amyloid A deposits detected in the tissue. This rules out AA amyloidosis. Other amyloid subtypes or non-amyloid conditions should be considered based on clinical context.

📊

Positive for SAA Amyloid - Diffuse Extracellular Staining

Amyloid A protein deposits detected with diffuse extracellular staining pattern. This confirms AA amyloidosis (secondary/reactive amyloidosis). Correlation with Congo Red birefringence is recommended for definitive diagnosis.

📊

Positive with Congo Red Co-localization

SAA amyloid deposits confirmed with apple-green birefringence under polarized light after Congo Red staining. This is diagnostic of AA amyloidosis. Treatment of the underlying chronic inflammatory condition is the primary therapeutic approach.

📊

Inconclusive / Non-specific Staining

Non-specific or equivocal staining pattern observed. Repeat testing with fresh tissue section, additional immunohistochemical markers, or mass spectrometry-based proteomics may be required for definitive subtyping.

⚠️ When to Consult a Doctor:

Consult your physician or specialist if you experience unexplained swelling in the ankles or legs, persistent shortness of breath, numbness or tingling in the hands or feet, unexplained fatigue, unexplained weight loss, difficulty swallowing, or changes in skin color — especially if you have a known chronic inflammatory condition such as rheumatoid arthritis, tuberculosis, or inflammatory bowel disease. Early diagnosis and treatment of the underlying condition can slow or prevent further amyloid deposition.

Limitations

  • IHC staining alone may not definitively classify amyloid in all cases; correlation with clinical history, Congo Red staining, and other ancillary tests is recommended
  • Sensitivity may be reduced in tissues with very early or minimal amyloid deposition
  • Rarely, cross-reactivity with non-amyloid proteins may occur
  • The test does not quantify the amount of amyloid deposition; it provides qualitative assessment
  • Fixed and processed tissues may have reduced antigen reactivity compared to fresh tissue

Risks & Considerations

  • This is a laboratory-based tissue test; it carries no direct risk to the patient from the test itself
  • The tissue biopsy procedure required to obtain the sample carries standard biopsy-related risks including bleeding, infection, and discomfort at the biopsy site, which should be discussed with the referring physician

Interfering Factors

  • Inadequate or improper tissue fixation may degrade antigen epitopes and produce false-negative results
  • Prolonged decalcification of bone tissue samples can damage SAA antigenicity
  • Excessive heat-induced antigen retrieval may cause background staining artifacts
  • Use of expired or improperly stored primary anti-SAA antibodies may yield unreliable results
  • Necrotic or severely autolyzed tissue may produce non-specific staining patterns

Compare With Similar Tests

TestImmunohistochemistry Serum Associated Amyloid (SAA) TestCongo Red Stain for AmyloidMass Spectrometry-based Amyloid TypingSerum Amyloid A (SAA) Blood Test
ComparisonImmunohistochemistry Serum Associated Amyloid (SAA) TestCongo Red staining detects the presence of amyloid deposits by demonstrating apple-green birefringence under polarized light but does not identify the specific amyloid protein type. IHC SAA is specifically used after Congo Red-positive identification to classify amyloid as AA type.Mass spectrometry proteomics provides the most definitive amyloid subtyping with high sensitivity and specificity. IHC SAA is more widely available and cost-effective but may require correlation with mass spectrometry in equivocal cases.Serum SAA blood test measures circulating SAA protein levels, indicating active inflammation and risk of AA amyloidosis development. IHC SAA tissue test confirms actual amyloid deposition in organs.

Frequently Asked Questions

What is the Immunohistochemistry SAA Test?
The Immunohistochemistry Serum Associated Amyloid (SAA) Test is a specialized tissue-based diagnostic test that uses immunohistochemical staining to detect amyloid A (AA) protein deposits in tissue samples. It is primarily used to diagnose and subtype AA amyloidosis, a condition caused by chronic inflammatory diseases.
What is the cost of the IHC SAA Test at DNA Labs India?
The cost of the Immunohistochemistry Serum Associated Amyloid (SAA) Test at DNA Labs India is INR 3500. This price includes test processing, immunohistochemical staining, pathologist interpretation, and digital report delivery.
What sample is required for the IHC SAA Test?
The test requires a tissue biopsy sample submitted in 10% formal-saline or as a formalin-fixed paraffin-embedded (FFPE) block. A copy of the histopathology report, biopsy site information, and clinical history must accompany the sample.
Is fasting required for the IHC SAA Test?
No, fasting is not required for this test. Since it is a tissue-based immunohistochemical test rather than a blood test, no dietary restrictions apply.
How long does it take to get the IHC SAA Test results?
Results are typically available within 5 to 7 business days. Block samples and tissue biopsy results are available in 5 days, while large complex tissue samples may take up to 7 business days.
What conditions are associated with AA amyloidosis?
AA amyloidosis is associated with chronic inflammatory conditions including rheumatoid arthritis, tuberculosis, ankylosing spondylitis, inflammatory bowel disease (Crohn's disease, ulcerative colitis), chronic osteomyelitis, and familial Mediterranean fever.
What is the difference between AA amyloidosis and AL amyloidosis?
AA amyloidosis is caused by deposition of serum amyloid A protein due to chronic inflammation, while AL amyloidosis is caused by deposition of immunoglobulin light chains associated with plasma cell disorders. The treatment approaches differ significantly, making accurate subtyping through IHC essential.
Does DNA Labs India offer home sample collection for this test?
Yes, DNA Labs India offers free home sample collection for the IHC SAA Test when booked online. However, since this test requires a tissue biopsy, the biopsy procedure itself must be performed at a hospital or clinic. The collected tissue sample can be picked up from the facility or patient's home for transport to the laboratory.
What does a positive IHC SAA result mean?
A positive result indicates the presence of amyloid A protein deposits in the tissue, confirming AA amyloidosis. This means the patient has secondary or reactive amyloidosis likely caused by an underlying chronic inflammatory condition. Your physician will recommend treating the underlying condition as the primary therapeutic approach.
What does a negative IHC SAA result mean?
A negative result means no amyloid A protein deposits were detected in the tissue sample. This effectively rules out AA amyloidosis. If amyloid deposits were previously identified by Congo Red staining, other amyloid subtypes (such as AL or ATTR) should be investigated using additional IHC markers or mass spectrometry.
Is the IHC SAA Test the same as the Serum Amyloid A blood test?
No, they are different tests. The IHC SAA Test examines tissue biopsy samples for actual amyloid A deposits in organs using immunohistochemistry. The Serum Amyloid A blood test measures circulating SAA protein levels in the blood, indicating active inflammation and risk of developing amyloidosis. The IHC test confirms established amyloid deposition, while the blood test assesses inflammation.
In which cities is home collection available for the IHC SAA Test?
DNA Labs India offers free home sample collection across major cities in India including Mumbai, Delhi, Bangalore, Hyderabad, Ahmedabad, Chennai, Kolkata, Surat, Pune, Jaipur, Lucknow, and many more. Please check the full list of cities on our website or contact our helpline for availability in your area.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.